• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Event Tracking

Nov6
ZHAOKE Ophthalmology Signs Distribution Agreement with PT Ferron Par Pharmaceuticals for BRIMOCHOL™ PF
09:46
Sep1
Zhaok 眼科's Core Drug Candidates Expected to be Approved for Market Entry Next Year
10:25
Zekewell Announces Interim Results, Anticipates Narrowing Losses, and Advances Multiple Product Development and Launch Plans
08:01
Aug28
ZHAOKE OPHTH-B released FY2025 Q1 earnings on August 28 (BJT), actual revenue HKD 8.462 M, actual EPS HKD -0.1143
15:00
ZHAOKE Ophthalmology-B Reports Increased Loss in Mid-Year Earnings
11:28
ZHAOKE OPHTH-B released FY2025 Semi-Annual Earnings on August 28 During-Market BJT, actual revenue HKD 17.11 M, actual EPS HKD -0.2312
08:00

Schedules & Filings

Schedules
Filings
Aug28
Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 8.648 M, Net Income -63.82 M, EPS -0.1168

Mar24
Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 10.4 M, Net Income -86.01 M, EPS -0.1574

Aug29
Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 26.74 M, Net Income -40.73 M, EPS -0.0752

View More

Stock List

Top Gainers
Top Decliners
Main Board
Symbol
Price
%Chg
Change
08583
0.090
+104.55%
+0.046
01172
0.034
+47.83%
+0.011
02906
0.260
+30.00%
+0.060
00756
0.660
+29.41%
+0.150
07311
14.860
+28.21%
+3.270
01201
1.000
+28.21%
+0.220
07399
75.260
+27.26%
+16.120
09311
1.898
+26.87%
+0.402
09399
9.635
+26.86%
+2.040
00648
0.260
+23.81%
+0.050
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy